Mom classroom ! free gift for you ![ Online Registration ]
0800-208-088
中文
0800-208-088
中文

Important Events
  1. 2001

    Established the 「Sino Cell Stem Cell Cryopreservation Center」 at the Bioresource Collection and Research Center (BCRC) of the FIRDI.

  2. 2002

    The research and development project 「Analytic System for the ex vivo Expansion of Hematopoietic Stem Cells」 was granted Small Business Innovation Research (SBIR) funding by the Ministry of Economic Affairs.
  3. 2003

    The 「Serum-free culture and Directed Differentiation of Umbilical Cord Blood-Derived Mesenchymal Stem Cells」 was granted SBIR funding by the Ministry of Economic Affairs.
  4. 2004

    The first institution in Taiwan to introduce the Taylor-Wharton’s LABS-80K large LN2 storage system.
  5. 2005

    The 「HSC ex vivo Expansion Technology」 was awarded international patent application number.
  6. 2006

    National Innovation Award was granted to the self-developed 「Portable Thermostatic Transporting Box for Umbilical Cord Blood.」
  7. 2007

    Collaborated with the medical teams from CGMH and NTUH to complete Taiwan’s first case on 「Treatment of Cerebral Palsy with Autologous Umbilical Cord Blood.」
  8. 2008

    Collaborated with the Taipei Medical University on 「The Establishment for Preservation and Quality Control Technology of Umbilical Cord and Amniotic Derived Mesenchymal Stem Cells.」
  9. 2009

    Signed a contract with the National Yang Ming University and become Taiwan’s first UCB stem cell company to be authorized for the patented cell culture technology for 「Umbilical Cord Mesenchymal Stem Cells.」
  10. 2010

    Industry-academic collaboration with the Yuan Ze University on the development of 「Isolation and ex vivo Expansion of Vascular Endothelial Precursor Cells in Umbilical Cord Blood.」
  11. 2012

    Combined with the SinoPac Life Insurance Agent Co. and Cathay Life Insurance to offer Taiwan’s first 「Health Insurance for Umbilical Cord Blood Transplantation (UCBT).」
  12. 2013

    Created the 「Peripheral Blood Stem Cell Bank」 and was audited and authorized by the Ministry of Health and Welfare to comply with the Regulations for Administration on Human Organ Bank.
  13. 2014

    Received exclusive U.S. Patent for 「Serum-free Culture Medium」; Patent Number US 8762074 B2.
  14. 2016

    Sino Cell Technologies, Ltd. (SCT) became the member bank of Cord Blood Association (CBA). CBA member banks include Cord Blood Registry (CBR, the No.1 family bank in the US), PerkinElmer Viacord, New York Blood Center, StemCell Institute, Inc (Tokyo, Japan) and other family and public banks from all over the world. Incumbent president is Dr. Joanne Kurtzberg, an internationally renowned expert in umbilical cord blood banking and transplantation from Duke University, School of Medicine. As a member of CBA, SCT has proved its technology in line with global standards. In the future, SCT will work with CBA closely in cord blood innovations, products, technologies, market expansion and services.